Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Incorporating Individual‐Level Treatment Effects and Outcome Preferences Into Personalized Blood Pressure Target Recommendations

Journal of the American Heart Association(2024)10.1161/jaha.124.033995Source: DataRank Database

Incorporating Individual‐Level Treatment Effects and Outcome Preferences Into Personalized Blood Pressure Target Recommendations is a research paper published in Journal of the American Heart Association (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (37 grants)Impact (FWCI 3.27)OA: goldTopics (86)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Richard L. Kravitz ORCID,Rebecca Scherzer ORCID,Jarett D. Berry ORCID,James A. de Lemos ORCID,Michelle M. Estrella ORCID

Live enrichment

PubMed:39136305 OpenAlex:https://openalex.org/W4401545984

National Institutes of Health

Grant: 1UL1RR025771-01

BOSTON UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) PROGRAM UL1

National Institutes of Health

Grant: 3UL1RR024134-06S2

Institutional Clinical and Translational Science Award

National Institutes of Health

Grant: 3UL1TR001064-02S1

Tufts Clinical and Translational Research Institute

National Institutes of Health

Grant: 8UL1TR000003-07

Institutional Clinical and Translational Science Award

National Institutes of Health

Grant: 3UL1TR000093-05S1

Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1

National Institutes of Health

Grant: 2UL1TR000439-06

Clinical and Translational Science Collaborative of Cleveland

National Institutes of Health

Grant: 5UL1TR000050-05

Center for Clinical and Translational Science

National Institutes of Health

Grant: 3UL1RR025752-02S4

TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCA

National Institutes of Health

Grant: 8UL1TR000073-05

Tufts Clinical and Translation Science Institute (UL1)

National Institutes of Health

Grant: 3UL1RR025755-04S1

The Ohio State University Center for Clinical and Translational Science (UL1)

NCATS NIH HHS

Grant: UL1 TR000433

NCATS NIH HHS

Grant: UL1 TR000445

NIDDK NIH HHS

Grant: R01 DK098234

NCATS NIH HHS

Grant: UL1 TR000064

NCATS NIH HHS

Grant: UL1 TR000075

NCATS NIH HHS

Grant: UL1 TR000093

NCATS NIH HHS

Grant: UL1 TR000003

NCATS NIH HHS

Grant: UL1 TR000050

NCATS NIH HHS

Grant: UL1 TR001420

NCRR NIH HHS

Grant: UL1 RR025755

NIDDK NIH HHS

Grant: K24 DK110427

NCATS NIH HHS

Grant: KL2 TR001859

NCRR NIH HHS

Grant: UL1 RR024134

NHLBI NIH HHS

Grant: HHSN268200900048C

NCATS NIH HHS

Grant: UL1 TR000005

NHLBI NIH HHS

Grant: HHSN268200900040C

NHLBI NIH HHS

Grant: HHSN268200900046C

NIGMS NIH HHS

Grant: P30 GM103337

NCATS NIH HHS

Grant: UL1 TR001064

NCRR NIH HHS

Grant: UL1 RR025752

NCRR NIH HHS

Grant: UL1 RR025771

NHLBI NIH HHS

Grant: HHSN268200900049C

NHLBI NIH HHS

Grant: HHSN268200900047C

NCATS NIH HHS

Grant: UL1 TR000439

NCATS NIH HHS

Grant: UL1 TR000073

NCATS NIH HHS

Grant: UL1 TR000002

NCATS NIH HHS

Grant: UL1 TR000105

FWCI

3.27

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.124.033995?download=true

publisherhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.124.033995?download=true

publisherhttps://www.ahajournals.org/doi/full/10.1161/JAHA.124.033995

journalhttps://doi.org/10.1161/jaha.124.033995

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39136305

Fields of Study

Blood Pressure and Hypertension StudiesHealth Systems, Economic Evaluations, Quality of LifeHemodynamic Monitoring and Therapy0302 clinical medicine03 medical and health sciencesAgedFemaleHumansMaleMiddle AgedAntihypertensive AgentsBlood PressureDecision Making, SharedHypertensionPatient PreferencePrecision MedicineRisk AssessmentTreatment OutcomeHealth Planning Guidelines

MeSH Terms

Decision Making, SharedAgedAntihypertensive AgentsBlood PressureFemaleHealth Planning GuidelinesHumansHypertensionMaleMiddle AgedTreatment OutcomeRisk AssessmentPatient PreferencePrecision Medicine

Keywords

MedicineInterquartile rangeBlood pressureSprintAdverse effectInternal medicinePhysical therapyMaleHealth Planning Guidelines (mesh)Clinical Research (rcdc)Brain Disorders (rcdc)Precision Medicine32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Original ResearchHumans (mesh)3 Good Health and Well Being (sdg)Treatment Outcome (mesh)3201 Cardiovascular medicine and haematology (for-2020)Patient PreferenceMiddle AgedTreatment OutcomeHypertensionCardiovascular (rcdc)Risk Assessment (mesh)FemaleHealth Planning GuidelinesClinical Trials and Supportive Activities (rcdc)Decision MakingRisk Assessmentshared decision‐making1102 Cardiorespiratory Medicine and Haematology (for)Middle Aged (mesh)Diseases of the circulatory (Cardiovascular) systemHumansHypertension (rcdc)Blood Pressure (mesh)Antihypertensive AgentsAgedCardiovascular (hrcs-hc)Patient Safety (rcdc)Aged (mesh)shared decision-makingShared (mesh)predictionAntihypertensive Agents (mesh)Female (mesh)RC666-701Patient Preference (mesh)Precision Medicine (mesh)patient preferencesDecision Making, SharedHypertension (mesh)

Sustainable Development Goals

SDG 16: 16. Peace & justiceSDG 0: Good health and well-being